Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Print health ad spend in US remains buoyant

Companies paid $45m on advertising in professional print journals in January 2014, a 7 per cent rise year-on-year

- PMLiVE

Interview: Georg Toufar, Mundipharma

Mundipharma’s chief marketing officer Georg Toufar on the benefits of having a smaller, more concentrated focus

- PMLiVE

GSK invests in African research and manufacturing

Boosts R&D for non-communicable diseases

Novartis day

Novartis’ dual-action heart failure drug aces trial

Ends LCZ696 trial early on good results

National Institute for Health and Care Excellence NICE logo

Final NICE ‘no’ for J&J’s Stelara in psoriatic arthritis

Committee says drug is more expensive and less effective than TNF alpha inhibitors

- PMLiVE

AZ teams up with UK’s MRC for discovery centre

Public-private facility will be based at the pharma company's Cambridge R&D site

08 UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

Havas Lynx

UX: Pushing the right buttons

Unlocking better outcomes in healthcare with UX

Havas Lynx

- PMLiVE

Merck & Co appoints new financial head

Baxter’s Robert Davis takes over from Peter Kellogg

- PMLiVE

Certainty comes too late

In the first of a new regular column, Professor Brian D Smith points out the practical implications of an evolving pharma market

Novartis building

FDA panel rejects Novartis’ heart failure hope serelaxin

Decision follows EMA knock back earlier this year

- PMLiVE

Pfizer gains ground in cholesterol antibody chase

 Reports positive phase 2b data for its PCSK9 blocker

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links